Life Sciences Call 2011 - Linking Research and Patients' NeedsLS11-008

A new treatment concept for lung injury

A new treatment concept for lung injury
Principal Investigator:
Project title:
A new treatment concept for lung injury
Completed (01.08.2011 – 30.04.2016)
Funding volume:
€ 492,800

Acute lung injury (ALI/ARDS) is a major problem at intense care units with mortality rates in the range of 40%. The main functional impediment in this disease resides at the alveolar-capillary barrier, which normally restricts fluid accumulation within the alveolar space thereby facilitating efficient gas exchange. This barrier is dysfunctional in ALI/ARDS, mainly through pathologic activation of RhoGTPases. Current therapies are only symptomatic, targeted therapies are missing. This project aims to develop new tools to improve alveolar-capillary barrier function through targeted interception of pathologic activation of RhoGTPases. Our unique position consists of the experienced team, access to a new and targeted inhibitor of RhoGTPases, and an unmet medical need with no approved drug on the market. Results of this work will serve as a starting point for a pharma-partner to initiate cost-intensive regulatory preclinical drug development.


We use cookies on our website. Some of them are technically necessary, while others help us to improve this website or provide additional functionalities. Further information